These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31226803)

  • 21. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
    J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound Elastography to Assess Botulinum Toxin A Treatment for Post-stroke Spasticity: A Feasibility Study.
    Gao J; Rubin JM; Chen J; O'Dell M
    Ultrasound Med Biol; 2019 May; 45(5):1094-1102. PubMed ID: 30898386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of botulinum toxin A for the treatment of hemiparesis in adults with chronic upper limb spasticity.
    Ghroubi S; Alila S; Elleuch W; Ayed HB; Mhiri C; Elleuch MH
    Pan Afr Med J; 2020; 35():55. PubMed ID: 32523646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects of Botulinum Toxin Injections on Plantar Flexor Spasticity in Different Phases After Stroke: A Secondary Analysis From a Double-Blind, Randomized Trial.
    Oh HM; Park GY; Choi YM; Koo HJ; Jang Y; Im S
    PM R; 2018 Aug; 10(8):789-797. PubMed ID: 29510234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity.
    Rekand T; Biering-Sörensen B; He J; Vilholm OJ; Christensen PB; Ulfarsson T; Belusa R; Ström T; Myrenfors P; Maisonobe P; Dalager T
    BMJ Open; 2019 May; 9(5):e024340. PubMed ID: 31061021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum neurotoxin-A in a patient with post-stroke spasticity: a neurophysiological study.
    Fawzi SM; Hamdan FB; Jaafar IF; Gawwam GAASA
    Folia Neuropathol; 2023; 61(4):412-418. PubMed ID: 38174669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
    Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
    Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients?
    Al-Khodairy AT; Gobelet C; Rossier AB
    Spinal Cord; 1998 Dec; 36(12):854-8. PubMed ID: 9881735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review.
    Mathevon L; Declemy A; Laffont I; Perennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):241-251. PubMed ID: 30980953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
    Simpson DM; Gracies JM; Yablon SA; Barbano R; Brashear A;
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):380-5. PubMed ID: 18977811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study.
    Baricich A; Picelli A; Carda S; Smania N; Cisari C; Santamato A; de Sire A; Invernizzi M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):214-219. PubMed ID: 31228593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation.
    Battaglia M; Cosenza L; Scotti L; Bertoni M; Polverelli M; Loro A; Santamato A; Baricich A
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study.
    Fietzek UM; Kossmehl P; Schelosky L; Ebersbach G; Wissel J
    Eur J Neurol; 2014 Aug; 21(8):1089-1095. PubMed ID: 24754350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial.
    Cinone N; Letizia S; Santoro L; Facciorusso S; Armiento R; Picelli A; Ranieri M; Santamato A
    Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 30965599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examining the role of intrinsic and reflexive contributions to ankle joint hyper-resistance treated with botulinum toxin-A.
    Van't Veld RC; Flux E; van Oorschot W; Schouten AC; van der Krogt MM; van der Kooij H; Vos-van der Hulst M; Keijsers NLW; van Asseldonk EHF
    J Neuroeng Rehabil; 2023 Feb; 20(1):19. PubMed ID: 36750869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of spasticity in spinal cord injury with botulinum toxin.
    Palazón-García R; Alcobendas-Maestro M; Esclarin-de Ruz A; Benavente-Valdepeñas AM
    J Spinal Cord Med; 2019 May; 42(3):281-287. PubMed ID: 29869974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of spasticity with botulinum toxin.
    O'Brien CF
    Clin J Pain; 2002; 18(6 Suppl):S182-90. PubMed ID: 12569967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.